ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines

BACKGROUND: Although 40–50% of non-small cell lung cancer (NSCLC) tumors respond to cisplatin chemotherapy, there currently is no way to prospectively identify potential responders. The purpose of this study was to determine whether transcript abundance (TA) levels of twelve selected DNA repair or m...

Descripción completa

Detalles Bibliográficos
Autores principales: Weaver, David A, Crawford, Erin L, Warner, Kristy A, Elkhairi, Fadel, Khuder, Sadik A, Willey, James C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156938/
https://www.ncbi.nlm.nih.gov/pubmed/15882455
http://dx.doi.org/10.1186/1476-4598-4-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156938/
https://www.ncbi.nlm.nih.gov/pubmed/15882455
http://dx.doi.org/10.1186/1476-4598-4-18

Ejemplares similares